ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Impact of Literacy Level on Patient Education and Health Among People With Arthritis

This study has been completed.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
ClinicalTrials.gov Identifier: NCT00023205
  Purpose

People with poor literacy may have worse health and less knowledge about how to manage their disease than patients at high reading levels. Patients with arthritis usually receive information on how to manage their disease that is written at an 11th grade reading level. The purpose of this study is to compare the health outcomes of patients with arthritis given either standard 11th grade level materials or interactive, in-person arthritis education along with materials written at a lower reading level.


Condition Intervention Phase
Rheumatoid Arthritis
Psoriatic Arthritis
Polyarthritis
Behavioral: 11th grade reading level arthritis materials
Behavioral: Interactive in-person arthritis education
Phase II

MedlinePlus related topics:   Rheumatoid Arthritis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Other, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Literacy in Arthritis Management: A Randomized Controlled Clinical Trial of a Novel Education Intervention

Further study details as provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):

Estimated Enrollment:   100
Study Start Date:   November 2002

Detailed Description:

Patients with poor literacy report worse health and know less about managing their disease than patients with better literacy. This study will compare the disease outcomes of arthritis patients at three different reading levels who receive either standard arthritis materials written at an 11th grade reading level or an in-person, interactive, text-free session along with lower reading level materials. The study will determine the most effective methods of educating patients with poor literacy about their disease.

Patients with systemic inflammatory rheumatic conditions (rheumatoid arthritis, psoriatic arthritis, and seronegative polyarthritis) will be assessed and placed into one of three reading levels: 8th grade or lower; 9th to 11th grade; or 12th grade or higher. Patients from each reading level will be randomly assigned to one of two intervention groups. Group 1 will receive disease-specific material from the Arthritis Foundation written at an 11th grade reading level. Group 2 will receive plain language materials, an arthritis glossary, and a one-hour, in-person session with a study educator using interactive, text-free methods. The study educator will help the patient with reading-related problems either by study visit or by telephone for 6 months postsession.

All patients will receive a medication calendar. Patients will be followed for one year after the intervention and will be assessed for changes in health status, disease activity, communication with the physician, self-management of their arthritis, understanding of and adherence to prescribed treatment, and satisfaction with their intervention.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Native English speaker
  • Patient at the Rheumatology Clinic at Brigham and Women's Hospital, Boston, Massachusetts
  • Diagnosis of rheumatoid arthritis, psoriatic arthritis, or seronegative polyarthritis
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00023205

Locations
United States, Massachusetts
Brigham and Women's Hospital    
      Boston, Massachusetts, United States, 02115

Sponsors and Collaborators

Investigators
Principal Investigator:     Matthew H. Liang, MD, MPH     Brigham and Women's Hospital    
  More Information


Publications:

Study ID Numbers:   P60 AR47782 NIAMS-068
First Received:   August 29, 2001
Last Updated:   April 26, 2007
ClinicalTrials.gov Identifier:   NCT00023205
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Arthritis  
Health literacy  
Patient education  
Self-efficacy  

Study placed in the following topic categories:
Spinal Diseases
Autoimmune Diseases
Skin Diseases
Arthritis, Psoriatic
Spondylarthropathy
Joint Diseases
Arthritis, Rheumatoid
Rheumatic Diseases
Bone Diseases
Polyarthritis
Musculoskeletal Diseases
Psoriasis
Arthritis
Connective Tissue Diseases
Spondylarthritis
Skin Diseases, Papulosquamous
Spondylarthropathies

Additional relevant MeSH terms:
Immune System Diseases

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers